HVHélène Vitet

Hélène Vitet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hélène Vitet has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Frédéric Saudou

    Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neuroscience

    4 shared publications
  • Julie Bruyère

    Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, CEA, Grenoble Institut Neurosciences, Grenoble, France

    2 shared publications
  • Agnès Rastetter

    INSERM, U 1127, CNRS UMR 7225, Faculté de Médecine de Sorbonne Université, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France

    1 shared publication
  • Alexandra J. Trott

    Department of Biology, Center for Biological Clocks Research, Texas A&M University, College Station, Texas 77843, USA

    1 shared publication
  • Aline Le Roy

    Institut de Biologie Structurale (IBS), University Grenoble Alpes, CEA, CNRS, Grenoble, France

    1 shared publication
  • Amy Dameron

    GeneDx, Gaithersburg, MD, 20877, USA

    1 shared publication

Latest Publications

  • Huntingtin functions in the regulation of axonal transport : consequences on neuronal network homeostasis and behavior, in health and disease

    by HélÈNE Vitet

    Conséquences de la régulation du transport axonal par la huntingtine sur l'homéostasie de réseaux neuronaux et sur le comportement, en conditions saine et pathologique: Les circuits neuronaux régissent les comportements tels que la coordination motrice ou la mémoire et l’apprentissage. Au sein d’un réseau, les neurones communiquent par des processus moléculaires et cellulaires finement réglés à la synapse. Un des mécanismes régulant l’homéostasie synaptique, le transport de vésicules dans les neurones, est dérégulé dans les maladies neurologiques telles que le syndrome de Rett, la maladie d’Alzheimer et la maladie d’Huntington. Ainsi, investiguer la régulation du transport de vésicules dans les neurites dans un contexte physiologique est important pour comprendre, et potentiellement rétablir, les conséquences de ces dérégulations pathologiques.La protéine Huntingtine (HTT), connue pour son implication dans la maladie d’Huntington, est un acteur clé du transport axonal. Elle promeut et influence le transport des vésicules en favorisant le recrutement des adaptateurs et des moteurs moléculaires. Sa phosphorylation sur la sérine 421 (pHTTS421) régule la directionnalité des vésicules de BDNF, d’APP et de VAMP-7 dans des neurones transfectés in vitro. Cependant, les mécanismes et les conséquences de la régulation du transport par HTT comme la spécificité neuritique et les conséquences comportementales restent peu connus. Enfin, nous ignorons si la régulation du transport peut être influencée dans des conditions pathologiques afin de restaurer les phénotypes in vivo.Ce projet de thèse vise à caractériser les mécanismes et les conséquences de la régulation du transport axonal de trois types de vésicules par pHTTS421 et d’investiguer sa propension à restaurer les phénotypes associés à des maladies neurologiques dans des modèles de souris.Dans le but de reproduire in vitro les réseaux associés à des maladies neurologiques, nous avons utilisé des chambres microfluidiques. Nous avons étudié le transport des vésicules d’APP, des précurseurs des vésicules synaptiques (PVSs) ou des vésicules à cœur dense (VCDs) contenant BDNF au sein d’un réseau neuronal dans lequel pHTTS421 a été modifiée. Ces neurones sont issus de souris pour lesquelles la sérine 421 a été remplacée par un acide aspartique ou par une alanine pour mimer respectivement l’état phosphorylé (HTTS421D) ou non phosphorylable (HTTS421A) de la HTT.Dans la maladie d’Alzheimer, l’homéostasie d’APP est dérégulée. Nous avons donc étudié son transport et son accumulation synaptique dans un circuit corticocortical. Nous avons trouvé que la phosphorylation de la sérine S421 par Akt régule la directionnalité des vésicules d’APP uniquement dans les axones : HTTS421A diminue le flux antérograde axonal d’APP ainsi que ses niveaux à la synapse in vitro et in vivo. Réduire le flux antérograde d’APP dans un modèle murin d’Alzheimer restaure l’homéostasie synaptique in vivo et les déficits de mémoire associés (publication 1 ; Bruyère*, Abada*, Vitet* et al., eLife, 2020).Le transport axonal des PVSs régule le nombre de vésicules synaptiques (VSs), ce qui, dans un réseau corticostriatal, est essentiel à l’apprentissage de compétences motrices. Nous avons montré que pHTTS421 augmente le recrutement de la kinésine KIF1A sur les PVSs, augmentant le transport antérograde et la probabilité d’exocytose. En réduisant les niveaux de KIF1A dans le réseau corticostriatal des souris HTTS421D, nous avons trouvé que pHTTS421 augmente le nombre de VSs et altère la mémoire procédurale. Cette étude décrit comment le transport axonal des PVSs impacte les phénotypes comportementaux (publication 2 ; vitet et al., in prep).Enfin, le transport de BDNF est dérégulé dans le réseau corticostriatal des jeunes filles atteintes du syndrome de Rett. Nous avons observé que l’expression endogène de pHTTS421 ou l’injection d’un composé inhibant la calcineurine (FK506) restaure le transport de BDNF dans un réseau corticostriatal, la communication neuronale et les symptômes associés chez les souris modèles du syndrome de Rett (Publication 3 ; Ehinger et al., Embo Mol Med, 2020).

  • Open Access

    The earliest circadian clock in the mammalian brain emerges in the embryonic choroid plexus

    by Hélène Vitet, Vuong Hung Truong, Jihwan Myung

    Maternal chronodisruption is linked to miscarriages and neurodevelopmental risks, yet the earliest brain circadian oscillator in the embryo and the mechanism of its emergence remain unknown. Using bioluminescent reporters for PER2 and Bmal1 , we tracked the onset of autonomous ∼24 h oscillations ex vivo . While the suprachiasmatic nucleus (SCN) is widely considered the first circadian structure at embryonic day (E) 14.5-15.5, we find that the fourth ventricle choroid plexus (4VCP) exhibits PER2 oscillations by E11.5-E12.5. These oscillations show hallmarks of a saddle-node on an invariant circle (SNIC) bifurcation, characterized by an initially long period converging toward 24 h and pronounced sensitivity to sub-degree temperature cycles mimicking physiological maternal cues. Transcriptional profiling of maternal and embryonic 4VCPs unveiled three epochs in clock gene expression that parallel tissue differentiation. We identify the 4VCP as the earliest detectable brain circadian oscillator, and demonstrate how its bifurcation dynamics allow the nascent clock to couple to maternal rhythms.


  • Open Access

    Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin

    by Julie Bruyère, Yah-Se Abada, Hélène Vitet, Gaëlle Fontaine, Jean-Christophe Deloulme, Aurélia Cès, Eric Denarier, Karin Pernet-Gallay, Annie Andrieux, Sandrine Humbert, et al.

    Studies have suggested that amyloid precursor protein (APP) regulates synaptic homeostasis, but the evidence has not been consistent. In particular, signaling pathways controlling APP transport to the synapse in axons and dendrites remain to be identified. Having previously shown that Huntingtin (HTT), the scaffolding protein involved in Huntington’s disease, regulates neuritic transport of APP, we used a microfluidic corticocortical neuronal network-on-a-chip to examine APP transport and localization to the pre- and post-synaptic compartments. We found that HTT, upon phosphorylation by the Ser/Thr kinase Akt, regulates APP transport in axons but not dendrites. Expression of an unphosphorylatable HTT decreased axonal anterograde transport of APP, reduced presynaptic APP levels, and increased synaptic density. Ablating in vivo HTT phosphorylation in APPPS1 mice, which overexpress APP, reduced presynaptic APP levels, restored synapse number and improved learning and memory. The Akt-HTT pathway and axonal transport of APP thus regulate APP presynaptic levels and synapse homeostasis.


  • Open Access

    Mutations in the KIF21B kinesin gene cause neurodevelopmental disorders through imbalanced canonical motor activity

    by Laure Asselin, José Rivera Alvarez, Solveig Heide, Camille S. Bonnet, Peggy Tilly, Hélène Vitet, Chantal Weber, Carlos A. Bacino, Kristin Baranaño, Anna Chassevent, et al.

    KIF21B is a kinesin protein that promotes intracellular transport and controls microtubule dynamics. We report three missense variants and one duplication in KIF21B in individuals with neurodevelopmental disorders associated with brain malformations, including corpus callosum agenesis (ACC) and microcephaly. We demonstrate, in vivo, that the expression of KIF21B missense variants specifically recapitulates patients’ neurodevelopmental abnormalities, including microcephaly and reduced intra- and inter-hemispheric connectivity. We establish that missense KIF21B variants impede neuronal migration through attenuation of kinesin autoinhibition leading to aberrant KIF21B motility activity. We also show that the ACC-related KIF21B variant independently perturbs axonal growth and ipsilateral axon branching through two distinct mechanisms, both leading to deregulation of canonical kinesin motor activity. The duplication introduces a premature termination codon leading to nonsense-mediated mRNA decay. Although we demonstrate that Kif21b haploinsufficiency leads to an impaired neuronal positioning, the duplication variant might not be pathogenic. Altogether, our data indicate that impaired KIF21B autoregulation and function play a critical role in the pathogenicity of human neurodevelopmental disorder.


  • Open Access

    Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice

    by Yann Ehinger, Julie Bruyère, Nicolas Panayotis, Yah‐Se Abada, Emilie Borloz, Valérie Matagne, Chiara Scaramuzzino, Hélène Vitet, Benoit Delatour, Lydia Saidi, et al.

    Mutations in the X‐linked MECP2 gene are responsible for Rett syndrome (RTT), a severe neurological disorder for which there is no treatment. Several studies have linked the loss of MeCP2 function to alterations of brain‐derived neurotrophic factor (BDNF) levels, but non‐specific overexpression of BDNF only partially improves the phenotype of Mecp2 ‐deficient mice. We and others have previously shown that huntingtin (HTT) scaffolds molecular motor complexes, transports BDNF‐containing vesicles, and is under‐expressed in Mecp2 knockout brains. Here, we demonstrate that promoting HTT phosphorylation at Ser421, either by a phospho‐mimetic mutation or inhibition of the phosphatase calcineurin, restores endogenous BDNF axonal transport in vitro in the corticostriatal pathway, increases striatal BDNF availability and synaptic connectivity in vivo, and improves the phenotype and the survival of Mecp2 knockout mice—even though treatments were initiated only after the mice had already developed symptoms. Stimulation of endogenous cellular pathways may thus be a promising approach for the treatment of RTT patients.


  • Open Access

    Tissue-specific BMAL1 cistromes reveal that rhythmic transcription is associated with rhythmic enhancer–enhancer interactions

    by Joshua R. Beytebiere, Alexandra J. Trott, Ben J. Greenwell, Collin A. Osborne, Helene Vitet, Jessica Spence, Seung-Hee Yoo, Zheng Chen, Joseph S. Takahashi, Noushin Ghaffari, et al.

    The mammalian circadian clock relies on the transcription factor CLOCK:BMAL1 to coordinate the rhythmic expression of thousands of genes. Consistent with the various biological functions under clock control, rhythmic gene expression is tissue-specific despite an identical clockwork mechanism in every cell. Here we show that BMAL1 DNA binding is largely tissue-specific, likely because of differences in chromatin accessibility between tissues and cobinding of tissue-specific transcription factors. Our results also indicate that BMAL1 ability to drive tissue-specific rhythmic transcription is associated with not only the activity of BMAL1-bound enhancers but also the activity of neighboring enhancers. Characterization of physical interactions between BMAL1 enhancers and other cis-regulatory regions by RNA polymerase II chromatin interaction analysis by paired-end tag (ChIA-PET) reveals that rhythmic BMAL1 target gene expression correlates with rhythmic chromatin interactions. These data thus support that much of BMAL1 target gene transcription depends on BMAL1 capacity to rhythmically regulate a network of enhancers.


  • Role of Phosphorylation in Moesin Interactions with PIP2-Containing Biomimetic Membranes

    by Quentin Lubart, Helene Vitet, Fabien Dalonneau, Aline Le Roy, Mathieu Kowalski, Morgane Lourdin, Christine Ebel, Marianne Weidenhaupt, Catherine Picart